Jens Bjørheim
Chief Tech/Sci/R&D Officer at ULTIMOVACS ASA
Profile
Jens Bjørheim is currently the Chief Medical Officer at Ultimovacs ASA. Previously, he worked as the Medical Director at Pronova BioPharma ASA from 2006 to 2008 and as the Senior Medical Director-Oncology at AstraZeneca A from 2013 to 2016.
He holds two doctorate degrees, one from the University of Oslo in 1999 and another from the same university in 2003.
Jens Bjørheim active positions
Companies | Position | Start |
---|---|---|
ULTIMOVACS ASA | Chief Tech/Sci/R&D Officer | - |
Former positions of Jens Bjørheim
Companies | Position | End |
---|---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 2015-12-31 |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Chief Tech/Sci/R&D Officer | 2007-12-31 |
Training of Jens Bjørheim
University of Oslo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ULTIMOVACS ASA | Health Technology |
Private companies | 2 |
---|---|
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Jens Bjørheim